Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. (AXDX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AXDX · as of Mar 31, 2025
Ownership Breakdown
1
Institutional Holders
$227,992
Total Inst. Value
▼ $162,295 vs Q4
25.29M
Shares Outstanding
freeFloat 53.24%
325,239
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AXDX largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BIRCHVIEW CAPITAL, LP laboratory analytical instruments | 325.2K | 1.40% | 1.40% | $227.99M | May 15, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AXDX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
2
Sell transactions
0.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Phillips Jack Chief Executive Officer | Apr 4, 2025 | Sale | 25,343 | $0.65 | $16.5K | 191.4K | Form 4 ↗ |
Mertz Larry Michael Chief Technology Officer | Apr 4, 2025 | Sale | 1,523 | $0.65 | $989.95 | 84.8K | Form 4 ↗ |
Patience David Chief Financial Officer | Apr 1, 2025 | Sale | 6,816 | $0.71 | $4.8K | 64.6K | Form 4 ↗ |
Patience David Chief Financial Officer | Feb 26, 2025 | Sale | 535 | $1.09 | $583.15 | 51.4K | Form 4 ↗ |
Phillips Jack Chief Executive Officer | Feb 3, 2025 | Sale | 485 | $1.35 | $654.75 | 163.4K | Form 4 ↗ |
PATIENCE JOHN director | Dec 3, 2024 | Purchase | 200,000 | $1.57 | $314.0K | 653.2K | Form 4 ↗ |
SCHULER JACK W
| Dec 3, 2024 | Sale | 200,000 | $1.57 | $314.0K | 8.31M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Accelerate Diagnostics, Inc. (AXDX) is primarily owned by institutional investors, who hold approximately 1.3% of total shares outstanding. Company insiders own approximately 46.76%, while retail and public investors account for the remaining 51.95%.
The largest institutional shareholder of Accelerate Diagnostics, Inc. is BIRCHVIEW CAPITAL, LP, holding approximately 325,239 shares — equal to 1.40% of outstanding shares — as of March 31, 2025.
A total of 1 institutional investors currently hold AXDX stock, with a combined institutional value of approximately $227,992 as of the most recent 13F filing period.
Frequently asked questions
AXDX ownershipAccelerate Diagnostics, Inc. (AXDX) is primarily owned by institutional investors, who hold approximately 1.3% of shares. The largest shareholder is BIRCHVIEW CAPITAL, LP with a 1.40% stake. Company insiders hold 46.76%. Data sourced from SEC Form 13F as of March 31, 2025.